Your browser doesn't support javascript.
loading
Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target.
Ankrom, Wendy; Wood, Harold B; Xu, Jiayi; Geissler, Wayne; Bateman, Tom; Chatterjee, Manash S; Feng, Kung-I; Metzger, Joseph M; Strapps, Walter R; Tadin-Strapps, Marija; Seiffert, Dietmar; Andre, Patrick.
Afiliação
  • Ankrom W; PPDM Merck & Co., Inc. Rahway New Jersey.
  • Wood HB; Discovery Chemistry Merck & Co., Inc. Rahway New Jersey.
  • Xu J; Discovery Chemistry Merck & Co., Inc. Rahway New Jersey.
  • Geissler W; In Vitro Pharmacology Merck & Co., Inc. Kenilworth New Jersey.
  • Bateman T; PPDM Merck & Co., Inc. Kenilworth New Jersey.
  • Chatterjee MS; PPDM Merck & Co., Inc. Rahway New Jersey.
  • Feng KI; Discovery Pharmaceutical Sciences Merck & Co., Inc. Rahway New Jersey.
  • Metzger JM; In Vitro Pharmacology Merck & Co., Inc. Kenilworth New Jersey.
  • Strapps WR; RNA Therapeutics Merck & Co., Inc. West Point Pennsylvania.
  • Tadin-Strapps M; Genetics and Pharmacogenomics Merck & Co., Inc. Boston Massachusetts.
  • Seiffert D; Cardiometabolic Disease Merck & Co., Inc. Kenilworth New Jersey.
  • Andre P; Cardiometabolic Disease Merck & Co., Inc. Kenilworth New Jersey.
Pharmacol Res Perspect ; 4(1): e00207, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26977298

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmacol Res Perspect Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmacol Res Perspect Ano de publicação: 2016 Tipo de documento: Article